Advisor Group Holdings, Inc. Aytu Biopharma, Inc Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.15 - $4.0 $15 - $400	-100 Reduced 1.62%	6,080 $1,000
Q2 2022 Aug 10, 2022	BUY	$0.46 - $1.08 $0 - $1	1 Added 0.02%	6,180 $4,000
Q1 2022 May 04, 2022	SELL	$1.08 - $1.55 $2,625 - $3,768	-2,431 Reduced 28.23%	6,179 $6,000
Q3 2021 Nov 05, 2021	BUY	$2.78 - $5.12 $16,793 - $30,929	6,041 Added 235.15%	8,610 $24,000
Q2 2021 Aug 02, 2021	BUY	$4.73 - $7.56 $11,257 - $17,992	2,380 Added 1259.26%	2,569 $13,000
Q1 2021 May 13, 2021	BUY	$6.23 - $9.88 $62 - $98	10 Added 5.59%	189 $2,000
Q4 2020 Feb 10, 2021	BUY	$5.98 - $13.5 $1,070 - $2,416	179 New	179 $1,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.